Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE: Longer vs Shorter Duration of Amoxicillin-clavulanic Acid for Pediatric Pneumonia
NCT02783859Phase 4Completed
- Sponsor
- Menzies School of Health Research
- Start
- Jun 2016
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial in community acquired pneumonia (CAP) comparing Active arm: Amoxicillin-clavulanic Acid with Placebo arm (2 arms). Primary endpoint: The proportion without chronic respiratory symptoms and signs or bronchiectasis at 24 months. Started Jun 2016; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT02783859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783859.